Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Specify a stock or a cryptocurrency in the search bar to get a summary
Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Iteos Therapeutics Inc
ITOSCurrent price
8.46 USD
-0.28 USD (-3.20%)
Last closed
8.83 USD
Company
www.iteostherapeutics.com
ISIN
US46565G1040
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Capitalization
338 557 088 USD
Yield for 12 month
-15.99 %
1Y
3Y
5Y
10Y
15Y
ITOS
Iteos Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the discovery and development of immuno-oncology therapeutics for patients with cancer. The company's lead antibody product candidate, belrestotug, an antagonist of TIGIT or T-cell immunoreceptor with Ig and ITIM domains, which is in Phase 1b clinical trial, as well as used to engage the Fc gamma receptor, or Fc"R to activate dendritic cells, natural killer cells, and macrophages and to promote antibody-dependent cellular cytotoxicity, or ADCC activity. Its product pipeline also includes inupadenant, a next-generation A2AR antagonists that is in Phase 1/2a clinical trials to overcome the specific adenosine-mediated immunosuppression found in tumor microenvironment; and EOS-984, a small molecule targeting equilibrative nucleoside transporter 1 (ENT1) to inhibit the immunosuppressive activity of adenosine and restore immune cell proliferation is in Phase 1 clinical trials. Iteos Therapeutics, Inc. was founded in 2011 and is headquartered in Watertown, Massachusetts. Address: 321 Arsenal Street, Watertown, MA, United States, 02472
Check your investment idea
Find the best to beat the market
TSLA
Tesla Motors
AAPL
Apple
MSFT
Microsoft
Analytics
WallStreet Target Price
34.5 USDP/E ratio
–Dividend Yield
–Current Year
+12 595 000 USD
Last Year
+267 630 000 USD
Current Quarter
+35 000 000 USD
Last Quarter
–
Current Year
+11 697 000 USD
Last Year
+266 817 000 USD
Current Quarter
+34 691 000 USD
Last Quarter
-303 000 USD
Key Figures ITOS
1 year
3 years
5 years
10 years
EBITDA
-139 264 992 USD
Operating Margin TTM
PE Ratio
–
Return On Assets TTM
-12.05 %
PEG Ratio
–
Return On Equity TTM
-16.8 %
Wall Street Target Price
34.5 USD
Revenue TTM
35 000 000 USD
Book Value
18.18 USD
Revenue Per Share TTM
Dividend Share
–
Quarterly Revenue Growth YOY
-100 %
Dividend Yield
–
Gross Profit TTM
267 630 000 USD
Earnings per share
-2.96 USD
Diluted Eps TTM
-2.96 USD
Most Recent Quarter
II 2024
Quarterly Earnings Growth YOY
-88.6 %
Profit Margin
–
Dividend Analytics ITOS
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
–Dividend History ITOS
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
–
Ex Dividend Date
–
Forward Annual Dividend Yield
–
Last Split Factor
–
Payout Ratio
–
Last Split Date
–
Dividend Date
–
Stock Valuation ITOS
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
–
Forward PE
12.5628
Enterprise Value Revenue
1.2621
Price Sales TTM
9.6731
Enterprise Value EBITDA
0.4956
Price Book MRQ
0.51
Financials ITOS
1 year
3 years
5 years
10 years
15 years
| Results | 2019 | Dynamics |
* The data for this period has not yet been published
Technical indicators ITOS
For 52 weeks
8.41 USD
18.75 USD
50 Day MA
10.99 USD
Shares Short Prior Month
4 815 858
200 Day MA
13.14 USD
Short Ratio
4.31
Shares Short
3 824 929
Short Percent
19.62 %
BeatStart